NCT05568212 2025-12-01Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and DurvalumabFondazione Ricerca TraslazionalePhase 2 Recruiting176 enrolled